Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Careers
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Pharmaceutical Manufacturers
  • Hospital and Healthcare Providers
  • Pharmacy
  • Governments
  • Private Payers and Insurers
  • Academics and Researchers
Pharmaceutical Manufacturers

Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.

Learn More
PHARMACEUTICAL MANUFACTURERS QUICK LINKS
Hospital and Healthcare Providers

Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.

Learn More
Pharmacy

A specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.

Learn More
PHARMACY QUICK LINKS
Governments

Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.

Learn More
Private Payers and Insurers

Health benefit analytics for effective response to market changes.

Learn More
Academics and Researchers

Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.

Learn More
MAIN/Insights
Insights/
INSIGHTS

Explore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.

Learn More
PHARMACEUTICAL TRENDS

Media representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.

Learn More

WEBINARS

"View our on-demand and upcoming webinars.

Learn More
MAIN/Careers
Careers/
CAREERS CANADA

Why work at IQVIA Canada? Help create a healthier world; start right here where we offer a diversity of opportunities.

DISCOVER CAREERS
OUR CULTURE

Our passion to make an impact is fueled by the people we work with, a curiosity to bring new ideas to life, and a focus on always doing better.

LEARN MORE

UNLEASH YOUR POTENTIAL

"Join IQVIA and see where your skills and competencies can take you.

APPLY NOW
MAIN/Contact Us
Contact Us/
Livre Blanc
Government Increases Oversight for Non-Accredited Educational Activities
Canadian Pharma Must Be Ready
Jun 14, 2019
  • Locations
  • Canada
  • Government Increases Oversight for Non-Accredited Educational Activities
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

How to Prepare for Key Regulatory Hurdles in Canada

A New IQVIA Commercial Compliance White Paper 

In a climate of increased scrutiny from regulatory bodies, the Canadian pharmaceutical industry should prepare for changes, perhaps significant; regarding the class of activities called Non-Accredited Educational Activities—also referred to as Other Learning Activities (OLAs). 

Health Canada, advertising preclearance agencies including the Pharmaceutical Advertising Advisory Board, Advertising Standards Canada and MIJO (formerly the Broadcast Clearance Advisory), as well as medical associations such as Innovative Medicines Canada, have all recently enhanced or clarified what is permitted and what is prohibited pertaining to pharmaceutical companies' development and execution of OLAs. These updates follow Health Canada's December 2018 launch of proactive monitoring of health products advertising.

Download this new IQVIA Commercial Compliance white paper, and discover:

  • How to prepare for these regulatory hurdles in Canada
  • The importance of comprehensive reporting
  • Key ways to implement compliance and risk mitigation strategies around OLAs
  • How IQVIA's industry leading solutions can help Life Sciences companies prepare for the expansion and enforcement of regulatory guidance
  • And more

For more information about IQVIA Commercial Compliance, please e-mail commercialcompliance@iqvia.com or visit our webpage. Our experts leverage the industry's leading technologies to deliver streamlined processes and improved efficiencies that solve your toughest engagement and transparency challenges. From automating and managing the entire HCP/O contracting lifecycle, to capturing, collecting, and reporting global spend; to planning efficient and compliant HCP meetings and engagements—discover how our solutions can make compliance easier for you.

Related solutions

Government

Use big data and predictive analytics to improve human health.

Industry Segments

See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.

Contact Us